Creative Medical Technology Holdings (CELZ) is a publicly traded commercial stage biotechnology company specializing in autologous and allogenic stem cell procedures in urology, neurology and orthopedics. CELZ has commercialized its Erectile Dysfunction technology and is announcing continued recruitment of physicians.

Creative Medical Technology Holdings Inc. (OTCQB ticker symbol CELZ) announced today the continued recruitment of physicians for its patented and clinically tested Caverstem™ procedure for the treatment of erectile dysfunction using the patient’s own bone marrow derived stem cells.

“Since commercialization of our Caverstem™ procedure began in..

View more at https://www.1888pressrelease.com/creative-medical-technology-holdings-inc-announces-continu-pr-629736.html